This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Evolva Sa. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Joanne Kelleher
Introduction
Joanne Kelleher is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate PPAR (Peroxisome Proliferator-Activated Receptor) activity. Her work is crucial in addressing various diseases, including diabetes and cancer.
Latest Patents
Joanne Kelleher holds a patent for "Substituted 1,3-dioxanes useful as PPAR modulators." This patent describes specifically useful stereoisomers of 1,3-dioxane derivatives. These compounds are valuable in the treatment of diseases or conditions dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders, and infections. Additionally, they are relevant in treating diseases related to TP, including cardiovascular diseases. She has 1 patent to her name.
Career Highlights
Kelleher is currently associated with Evolva SA, a company known for its innovative approaches in biotechnology. Her role at Evolva has allowed her to focus on research and development, contributing to advancements in therapeutic solutions.
Collaborations
Joanne has collaborated with notable colleagues, including Prathama Satyendra Mainkar and David Pearson. These collaborations have enhanced her research efforts and broadened the impact of her work in the scientific community.
Conclusion
Joanne Kelleher's innovative work in the field of PPAR modulators showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against various diseases, and her patent reflects her commitment to improving health outcomes.